CTOR Q1 2026 Earnings Significant EPS Miss Amid PreRevenue Phase Red River Bancshares Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting GAINN Q1 2026 Earnings EPS Misses Estimates by 88 Stock Unchanged L3Harris Technologies Q1 2026 Earnings EPS Beat Fuels Positive Stock Reaction IMMR Q3 2025 Earnings EPS Beat Drives Positive Market Reaction Licensing Revenue Remains Opaque